img

Global Rifamycin SV Monosodium Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Rifamycin SV Monosodium Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Rifamycin SV Monosodium belongs to the class of antibiotics and is used for combined treatment of tuberculosis infection and severe methicillin-resistant Staphylococcus aureus, surface Staphylococcus and refractory Legionella infection.
Rifamycin SV Monosodium report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Rifamycin SV Monosodium market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Bacterial Infections and Leprosy are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Rifamycin SV Monosodium industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Rifamycin SV Monosodium key manufacturers include Biomol, Biorbyt, LKT Laboratories, Cayman Chemical, Universal Biologicals, AbMole BioScience, CymitQuimica, LEAPChem and Manus Aktteva Biopharma, etc. Biomol, Biorbyt, LKT Laboratories are top 3 players and held % sales share in total in 2022.
Rifamycin SV Monosodium can be divided into Purity Less Than 98%, Purity 98%-99% and Purity Greater Than 99%,, etc. Purity Less Than 98% is the mainstream product in the market, accounting for % sales share globally in 2022.
Rifamycin SV Monosodium is widely used in various fields, such as Bacterial Infections, Leprosy and Others,, etc. Bacterial Infections provides greatest supports to the Rifamycin SV Monosodium industry development. In 2022, global % sales of Rifamycin SV Monosodium went into Bacterial Infections filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Rifamycin SV Monosodium market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Biomol
Biorbyt
LKT Laboratories
Cayman Chemical
Universal Biologicals
AbMole BioScience
CymitQuimica
LEAPChem
Manus Aktteva Biopharma
Shenyang Antibiotic Manufacturer
Zhejiang Hengtengfu Biological Technology Group
Wuhan Fortuna Chemical
Hubei Rishengchang New Material Technology
Jiang Xi Revere Biotechnology
Shanghai Yuanye Bio-Technology
Segment by Type
Purity Less Than 98%
Purity 98%-99%
Purity Greater Than 99%

Segment by Application


Bacterial Infections
Leprosy
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Rifamycin SV Monosodium market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Rifamycin SV Monosodium, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Rifamycin SV Monosodium industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Rifamycin SV Monosodium in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Rifamycin SV Monosodium introduction, etc. Rifamycin SV Monosodium Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Rifamycin SV Monosodium market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Rifamycin SV Monosodium Market Overview
1.1 Rifamycin SV Monosodium Product Overview
1.2 Rifamycin SV Monosodium Market Segment by Type
1.2.1 Purity Less Than 98%
1.2.2 Purity 98%-99%
1.2.3 Purity Greater Than 99%
1.3 Global Rifamycin SV Monosodium Market Size by Type
1.3.1 Global Rifamycin SV Monosodium Market Size Overview by Type (2018-2029)
1.3.2 Global Rifamycin SV Monosodium Historic Market Size Review by Type (2018-2024)
1.3.3 Global Rifamycin SV Monosodium Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Rifamycin SV Monosodium Sales Breakdown by Type (2018-2024)
1.4.2 Europe Rifamycin SV Monosodium Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Rifamycin SV Monosodium Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Rifamycin SV Monosodium Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Rifamycin SV Monosodium Sales Breakdown by Type (2018-2024)
2 Global Rifamycin SV Monosodium Market Competition by Company
2.1 Global Top Players by Rifamycin SV Monosodium Sales (2018-2024)
2.2 Global Top Players by Rifamycin SV Monosodium Revenue (2018-2024)
2.3 Global Top Players by Rifamycin SV Monosodium Price (2018-2024)
2.4 Global Top Manufacturers Rifamycin SV Monosodium Manufacturing Base Distribution, Sales Area, Product Type
2.5 Rifamycin SV Monosodium Market Competitive Situation and Trends
2.5.1 Rifamycin SV Monosodium Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Rifamycin SV Monosodium Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Rifamycin SV Monosodium as of 2022)
2.7 Date of Key Manufacturers Enter into Rifamycin SV Monosodium Market
2.8 Key Manufacturers Rifamycin SV Monosodium Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Rifamycin SV Monosodium Status and Outlook by Region
3.1 Global Rifamycin SV Monosodium Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Rifamycin SV Monosodium Historic Market Size by Region
3.2.1 Global Rifamycin SV Monosodium Sales in Volume by Region (2018-2024)
3.2.2 Global Rifamycin SV Monosodium Sales in Value by Region (2018-2024)
3.2.3 Global Rifamycin SV Monosodium Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Rifamycin SV Monosodium Forecasted Market Size by Region
3.3.1 Global Rifamycin SV Monosodium Sales in Volume by Region (2024-2029)
3.3.2 Global Rifamycin SV Monosodium Sales in Value by Region (2024-2029)
3.3.3 Global Rifamycin SV Monosodium Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Rifamycin SV Monosodium by Application
4.1 Rifamycin SV Monosodium Market Segment by Application
4.1.1 Bacterial Infections
4.1.2 Leprosy
4.1.3 Others
4.2 Global Rifamycin SV Monosodium Market Size by Application
4.2.1 Global Rifamycin SV Monosodium Market Size Overview by Application (2018-2029)
4.2.2 Global Rifamycin SV Monosodium Historic Market Size Review by Application (2018-2024)
4.2.3 Global Rifamycin SV Monosodium Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Rifamycin SV Monosodium Sales Breakdown by Application (2018-2024)
4.3.2 Europe Rifamycin SV Monosodium Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Rifamycin SV Monosodium Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Rifamycin SV Monosodium Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Rifamycin SV Monosodium Sales Breakdown by Application (2018-2024)
5 North America Rifamycin SV Monosodium by Country
5.1 North America Rifamycin SV Monosodium Historic Market Size by Country
5.1.1 North America Rifamycin SV Monosodium Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Rifamycin SV Monosodium Sales in Volume by Country (2018-2024)
5.1.3 North America Rifamycin SV Monosodium Sales in Value by Country (2018-2024)
5.2 North America Rifamycin SV Monosodium Forecasted Market Size by Country
5.2.1 North America Rifamycin SV Monosodium Sales in Volume by Country (2024-2029)
5.2.2 North America Rifamycin SV Monosodium Sales in Value by Country (2024-2029)
6 Europe Rifamycin SV Monosodium by Country
6.1 Europe Rifamycin SV Monosodium Historic Market Size by Country
6.1.1 Europe Rifamycin SV Monosodium Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Rifamycin SV Monosodium Sales in Volume by Country (2018-2024)
6.1.3 Europe Rifamycin SV Monosodium Sales in Value by Country (2018-2024)
6.2 Europe Rifamycin SV Monosodium Forecasted Market Size by Country
6.2.1 Europe Rifamycin SV Monosodium Sales in Volume by Country (2024-2029)
6.2.2 Europe Rifamycin SV Monosodium Sales in Value by Country (2024-2029)
7 Asia-Pacific Rifamycin SV Monosodium by Region
7.1 Asia-Pacific Rifamycin SV Monosodium Historic Market Size by Region
7.1.1 Asia-Pacific Rifamycin SV Monosodium Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Rifamycin SV Monosodium Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Rifamycin SV Monosodium Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Rifamycin SV Monosodium Forecasted Market Size by Region
7.2.1 Asia-Pacific Rifamycin SV Monosodium Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Rifamycin SV Monosodium Sales in Value by Region (2024-2029)
8 Latin America Rifamycin SV Monosodium by Country
8.1 Latin America Rifamycin SV Monosodium Historic Market Size by Country
8.1.1 Latin America Rifamycin SV Monosodium Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Rifamycin SV Monosodium Sales in Volume by Country (2018-2024)
8.1.3 Latin America Rifamycin SV Monosodium Sales in Value by Country (2018-2024)
8.2 Latin America Rifamycin SV Monosodium Forecasted Market Size by Country
8.2.1 Latin America Rifamycin SV Monosodium Sales in Volume by Country (2024-2029)
8.2.2 Latin America Rifamycin SV Monosodium Sales in Value by Country (2024-2029)
9 Middle East and Africa Rifamycin SV Monosodium by Country
9.1 Middle East and Africa Rifamycin SV Monosodium Historic Market Size by Country
9.1.1 Middle East and Africa Rifamycin SV Monosodium Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Rifamycin SV Monosodium Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Rifamycin SV Monosodium Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Rifamycin SV Monosodium Forecasted Market Size by Country
9.2.1 Middle East and Africa Rifamycin SV Monosodium Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Rifamycin SV Monosodium Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Biomol
10.1.1 Biomol Company Information
10.1.2 Biomol Introduction and Business Overview
10.1.3 Biomol Rifamycin SV Monosodium Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Biomol Rifamycin SV Monosodium Products Offered
10.1.5 Biomol Recent Development
10.2 Biorbyt
10.2.1 Biorbyt Company Information
10.2.2 Biorbyt Introduction and Business Overview
10.2.3 Biorbyt Rifamycin SV Monosodium Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Biorbyt Rifamycin SV Monosodium Products Offered
10.2.5 Biorbyt Recent Development
10.3 LKT Laboratories
10.3.1 LKT Laboratories Company Information
10.3.2 LKT Laboratories Introduction and Business Overview
10.3.3 LKT Laboratories Rifamycin SV Monosodium Sales, Revenue and Gross Margin (2018-2024)
10.3.4 LKT Laboratories Rifamycin SV Monosodium Products Offered
10.3.5 LKT Laboratories Recent Development
10.4 Cayman Chemical
10.4.1 Cayman Chemical Company Information
10.4.2 Cayman Chemical Introduction and Business Overview
10.4.3 Cayman Chemical Rifamycin SV Monosodium Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Cayman Chemical Rifamycin SV Monosodium Products Offered
10.4.5 Cayman Chemical Recent Development
10.5 Universal Biologicals
10.5.1 Universal Biologicals Company Information
10.5.2 Universal Biologicals Introduction and Business Overview
10.5.3 Universal Biologicals Rifamycin SV Monosodium Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Universal Biologicals Rifamycin SV Monosodium Products Offered
10.5.5 Universal Biologicals Recent Development
10.6 AbMole BioScience
10.6.1 AbMole BioScience Company Information
10.6.2 AbMole BioScience Introduction and Business Overview
10.6.3 AbMole BioScience Rifamycin SV Monosodium Sales, Revenue and Gross Margin (2018-2024)
10.6.4 AbMole BioScience Rifamycin SV Monosodium Products Offered
10.6.5 AbMole BioScience Recent Development
10.7 CymitQuimica
10.7.1 CymitQuimica Company Information
10.7.2 CymitQuimica Introduction and Business Overview
10.7.3 CymitQuimica Rifamycin SV Monosodium Sales, Revenue and Gross Margin (2018-2024)
10.7.4 CymitQuimica Rifamycin SV Monosodium Products Offered
10.7.5 CymitQuimica Recent Development
10.8 LEAPChem
10.8.1 LEAPChem Company Information
10.8.2 LEAPChem Introduction and Business Overview
10.8.3 LEAPChem Rifamycin SV Monosodium Sales, Revenue and Gross Margin (2018-2024)
10.8.4 LEAPChem Rifamycin SV Monosodium Products Offered
10.8.5 LEAPChem Recent Development
10.9 Manus Aktteva Biopharma
10.9.1 Manus Aktteva Biopharma Company Information
10.9.2 Manus Aktteva Biopharma Introduction and Business Overview
10.9.3 Manus Aktteva Biopharma Rifamycin SV Monosodium Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Manus Aktteva Biopharma Rifamycin SV Monosodium Products Offered
10.9.5 Manus Aktteva Biopharma Recent Development
10.10 Shenyang Antibiotic Manufacturer
10.10.1 Shenyang Antibiotic Manufacturer Company Information
10.10.2 Shenyang Antibiotic Manufacturer Introduction and Business Overview
10.10.3 Shenyang Antibiotic Manufacturer Rifamycin SV Monosodium Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Shenyang Antibiotic Manufacturer Rifamycin SV Monosodium Products Offered
10.10.5 Shenyang Antibiotic Manufacturer Recent Development
10.11 Zhejiang Hengtengfu Biological Technology Group
10.11.1 Zhejiang Hengtengfu Biological Technology Group Company Information
10.11.2 Zhejiang Hengtengfu Biological Technology Group Introduction and Business Overview
10.11.3 Zhejiang Hengtengfu Biological Technology Group Rifamycin SV Monosodium Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Zhejiang Hengtengfu Biological Technology Group Rifamycin SV Monosodium Products Offered
10.11.5 Zhejiang Hengtengfu Biological Technology Group Recent Development
10.12 Wuhan Fortuna Chemical
10.12.1 Wuhan Fortuna Chemical Company Information
10.12.2 Wuhan Fortuna Chemical Introduction and Business Overview
10.12.3 Wuhan Fortuna Chemical Rifamycin SV Monosodium Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Wuhan Fortuna Chemical Rifamycin SV Monosodium Products Offered
10.12.5 Wuhan Fortuna Chemical Recent Development
10.13 Hubei Rishengchang New Material Technology
10.13.1 Hubei Rishengchang New Material Technology Company Information
10.13.2 Hubei Rishengchang New Material Technology Introduction and Business Overview
10.13.3 Hubei Rishengchang New Material Technology Rifamycin SV Monosodium Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Hubei Rishengchang New Material Technology Rifamycin SV Monosodium Products Offered
10.13.5 Hubei Rishengchang New Material Technology Recent Development
10.14 Jiang Xi Revere Biotechnology
10.14.1 Jiang Xi Revere Biotechnology Company Information
10.14.2 Jiang Xi Revere Biotechnology Introduction and Business Overview
10.14.3 Jiang Xi Revere Biotechnology Rifamycin SV Monosodium Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Jiang Xi Revere Biotechnology Rifamycin SV Monosodium Products Offered
10.14.5 Jiang Xi Revere Biotechnology Recent Development
10.15 Shanghai Yuanye Bio-Technology
10.15.1 Shanghai Yuanye Bio-Technology Company Information
10.15.2 Shanghai Yuanye Bio-Technology Introduction and Business Overview
10.15.3 Shanghai Yuanye Bio-Technology Rifamycin SV Monosodium Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Shanghai Yuanye Bio-Technology Rifamycin SV Monosodium Products Offered
10.15.5 Shanghai Yuanye Bio-Technology Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Rifamycin SV Monosodium Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Rifamycin SV Monosodium Industrial Chain Analysis
11.4 Rifamycin SV Monosodium Market Dynamics
11.4.1 Rifamycin SV Monosodium Industry Trends
11.4.2 Rifamycin SV Monosodium Market Drivers
11.4.3 Rifamycin SV Monosodium Market Challenges
11.4.4 Rifamycin SV Monosodium Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Rifamycin SV Monosodium Distributors
12.3 Rifamycin SV Monosodium Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Purity Less Than 98%
Table 2. Major Company of Purity 98%-99%
Table 3. Major Company of Purity Greater Than 99%
Table 4. Global Rifamycin SV Monosodium Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Rifamycin SV Monosodium Sales by Type (2018-2024) & (Tons)
Table 6. Global Rifamycin SV Monosodium Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Rifamycin SV Monosodium Sales by Type (2018-2024) & (US& Million)
Table 8. Global Rifamycin SV Monosodium Market Share in Value by Type (2018-2024)
Table 9. Global Rifamycin SV Monosodium Price by Type (2018-2024) & (US$/Ton)
Table 10. Global Rifamycin SV Monosodium Sales by Type (2024-2029) & (Tons)
Table 11. Global Rifamycin SV Monosodium Sales Market Share in Volume by Type (2024-2029)
Table 12. Global Rifamycin SV Monosodium Sales by Type (2024-2029) & (US$ Million)
Table 13. Global Rifamycin SV Monosodium Sales Market Share in Value by Type (2024-2029)
Table 14. Global Rifamycin SV Monosodium Price by Type (2024-2029) & (US$/Ton)
Table 15. North America Rifamycin SV Monosodium Sales by Type (2018-2024) & (Tons)
Table 16. North America Rifamycin SV Monosodium Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Rifamycin SV Monosodium Sales (Tons) by Type (2018-2024)
Table 18. Europe Rifamycin SV Monosodium Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Rifamycin SV Monosodium Sales (Tons) by Type (2018-2024)
Table 20. Asia-Pacific Rifamycin SV Monosodium Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Rifamycin SV Monosodium Sales (Tons) by Type (2018-2024)
Table 22. Latin America Rifamycin SV Monosodium Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Rifamycin SV Monosodium Sales (Tons) by Type (2018-2024)
Table 24. Middle East and Africa Rifamycin SV Monosodium Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Rifamycin SV Monosodium Sales by Company (2018-2024) & (Tons)
Table 26. Global Rifamycin SV Monosodium Sales Share by Company (2018-2024)
Table 27. Global Rifamycin SV Monosodium Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Rifamycin SV Monosodium Revenue Share by Company (2018-2024)
Table 29. Global Market Rifamycin SV Monosodium Price by Company (2018-2024) & (US$/Ton)
Table 30. Global Rifamycin SV Monosodium Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Rifamycin SV Monosodium Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Rifamycin SV Monosodium as of 2022)
Table 33. Date of Key Manufacturers Enter into Rifamycin SV Monosodium Market
Table 34. Key Manufacturers Rifamycin SV Monosodium Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Rifamycin SV Monosodium Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 37. Global Rifamycin SV Monosodium Sales by Region (2018-2024) & (Tons)
Table 38. Global Rifamycin SV Monosodium Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Rifamycin SV Monosodium Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Rifamycin SV Monosodium Sales Market Share in Value by Region (2018-2024)
Table 41. Global Rifamycin SV Monosodium Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2018-2024)
Table 42. Global Rifamycin SV Monosodium Sales by Region (2024-2029) & (Tons)
Table 43. Global Rifamycin SV Monosodium Sales Market Share in Volume by Region (2024-2029)
Table 44. Global Rifamycin SV Monosodium Sales by Region (2024-2029) & (US$ Million)
Table 45. Global Rifamycin SV Monosodium Sales Market Share in Value by Region (2024-2029)
Table 46. Global Rifamycin SV Monosodium Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2024-2029)
Table 47. Global Rifamycin SV Monosodium Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 48. Global Rifamycin SV Monosodium Sales by Application (2018-2024) & (Tons)
Table 49. Global Rifamycin SV Monosodium Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Rifamycin SV Monosodium Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Rifamycin SV Monosodium Sales Market Share in Value by Application (2018-2024)
Table 52. Global Rifamycin SV Monosodium Price by Application (2018-2024) & (US$/Ton)
Table 53. Global Rifamycin SV Monosodium Sales by Application (2024-2029) & (Tons)
Table 54. Global Rifamycin SV Monosodium Sales Market Share in Volume by Application (2024-2029)
Table 55. Global Rifamycin SV Monosodium Sales by Application (2024-2029) & (US$ Million)
Table 56. Global Rifamycin SV Monosodium Sales Market Share in Value by Application (2024-2029)
Table 57. Global Rifamycin SV Monosodium Price by Application (2024-2029) & (US$/Ton)
Table 58. North America Rifamycin SV Monosodium Sales by Application (2018-2024) (Tons)
Table 59. North America Rifamycin SV Monosodium Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Rifamycin SV Monosodium Sales by Application (2018-2024) (Tons)
Table 61. Europe Rifamycin SV Monosodium Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Rifamycin SV Monosodium Sales by Application (2018-2024) (Tons)
Table 63. Asia-Pacific Rifamycin SV Monosodium Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Rifamycin SV Monosodium Sales by Application (2018-2024) (Tons)
Table 65. Latin America Rifamycin SV Monosodium Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Rifamycin SV Monosodium Sales by Application (2018-2024) (Tons)
Table 67. Middle East and Africa Rifamycin SV Monosodium Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Rifamycin SV Monosodium Sales by Country (2018-2024) & (Tons)
Table 69. North America Rifamycin SV Monosodium Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Rifamycin SV Monosodium Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Rifamycin SV Monosodium Sales Market Share in Value by Country (2018-2024)
Table 72. North America Rifamycin SV Monosodium Sales by Country (2024-2029) & (Tons)
Table 73. North America Rifamycin SV Monosodium Sales Market Share in Volume by Country (2024-2029)
Table 74. North America Rifamycin SV Monosodium Sales by Country (2024-2029) & (US$ Million)
Table 75. North America Rifamycin SV Monosodium Sales Market Share in Value by Country (2024-2029)
Table 76. Europe Rifamycin SV Monosodium Sales by Country (2018-2024) & (Tons)
Table 77. Europe Rifamycin SV Monosodium Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Rifamycin SV Monosodium Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Rifamycin SV Monosodium Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Rifamycin SV Monosodium Sales by Country (2024-2029) & (Tons)
Table 81. Europe Rifamycin SV Monosodium Sales Market Share in Volume by Country (2024-2029)
Table 82. Europe Rifamycin SV Monosodium Sales by Country (2024-2029) & (US$ Million)
Table 83. Europe Rifamycin SV Monosodium Sales Market Share in Value by Country (2024-2029)
Table 84. Asia-Pacific Rifamycin SV Monosodium Sales by Region (2018-2024) & (Tons)
Table 85. Asia-Pacific Rifamycin SV Monosodium Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Rifamycin SV Monosodium Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Rifamycin SV Monosodium Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Rifamycin SV Monosodium Sales by Region (2024-2029) & (Tons)
Table 89. Asia-Pacific Rifamycin SV Monosodium Sales Market Share in Volume by Region (2024-2029)
Table 90. Asia-Pacific Rifamycin SV Monosodium Sales by Region (2024-2029) & (US$ Million)
Table 91. Asia-Pacific Rifamycin SV Monosodium Sales Market Share in Value by Region (2024-2029)
Table 92. Latin America Rifamycin SV Monosodium Sales by Country (2018-2024) & (Tons)
Table 93. Latin America Rifamycin SV Monosodium Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Rifamycin SV Monosodium Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Rifamycin SV Monosodium Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Rifamycin SV Monosodium Sales by Country (2024-2029) & (Tons)
Table 97. Latin America Rifamycin SV Monosodium Sales Market Share in Volume by Country (2024-2029)
Table 98. Latin America Rifamycin SV Monosodium Sales by Country (2024-2029) & (US$ Million)
Table 99. Latin America Rifamycin SV Monosodium Sales Market Share in Value by Country (2024-2029)
Table 100. Middle East and Africa Rifamycin SV Monosodium Sales by Country (2018-2024) & (Tons)
Table 101. Middle East and Africa Rifamycin SV Monosodium Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Rifamycin SV Monosodium Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Rifamycin SV Monosodium Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Rifamycin SV Monosodium Sales by Country (2024-2029) & (Tons)
Table 105. Middle East and Africa Rifamycin SV Monosodium Sales Market Share in Volume by Country (2024-2029)
Table 106. Middle East and Africa Rifamycin SV Monosodium Sales by Country (2024-2029) & (US$ Million)
Table 107. Middle East and Africa Rifamycin SV Monosodium Sales Market Share in Value by Country (2024-2029)
Table 108. Biomol Company Information
Table 109. Biomol Introduction and Business Overview
Table 110. Biomol Rifamycin SV Monosodium Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2024)
Table 111. Biomol Rifamycin SV Monosodium Product
Table 112. Biomol Recent Development
Table 113. Biorbyt Company Information
Table 114. Biorbyt Introduction and Business Overview
Table 115. Biorbyt Rifamycin SV Monosodium Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2024)
Table 116. Biorbyt Rifamycin SV Monosodium Product
Table 117. Biorbyt Recent Development
Table 118. LKT Laboratories Company Information
Table 119. LKT Laboratories Introduction and Business Overview
Table 120. LKT Laboratories Rifamycin SV Monosodium Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2024)
Table 121. LKT Laboratories Rifamycin SV Monosodium Product
Table 122. LKT Laboratories Recent Development
Table 123. Cayman Chemical Company Information
Table 124. Cayman Chemical Introduction and Business Overview
Table 125. Cayman Chemical Rifamycin SV Monosodium Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2024)
Table 126. Cayman Chemical Rifamycin SV Monosodium Product
Table 127. Cayman Chemical Recent Development
Table 128. Universal Biologicals Company Information
Table 129. Universal Biologicals Introduction and Business Overview
Table 130. Universal Biologicals Rifamycin SV Monosodium Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2024)
Table 131. Universal Biologicals Rifamycin SV Monosodium Product
Table 132. Universal Biologicals Recent Development
Table 133. AbMole BioScience Company Information
Table 134. AbMole BioScience Introduction and Business Overview
Table 135. AbMole BioScience Rifamycin SV Monosodium Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2024)
Table 136. AbMole BioScience Rifamycin SV Monosodium Product
Table 137. AbMole BioScience Recent Development
Table 138. CymitQuimica Company Information
Table 139. CymitQuimica Introduction and Business Overview
Table 140. CymitQuimica Rifamycin SV Monosodium Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2024)
Table 141. CymitQuimica Rifamycin SV Monosodium Product
Table 142. CymitQuimica Recent Development
Table 143. LEAPChem Company Information
Table 144. LEAPChem Introduction and Business Overview
Table 145. LEAPChem Rifamycin SV Monosodium Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2024)
Table 146. LEAPChem Rifamycin SV Monosodium Product
Table 147. LEAPChem Recent Development
Table 148. Manus Aktteva Biopharma Company Information
Table 149. Manus Aktteva Biopharma Introduction and Business Overview
Table 150. Manus Aktteva Biopharma Rifamycin SV Monosodium Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2024)
Table 151. Manus Aktteva Biopharma Rifamycin SV Monosodium Product
Table 152. Manus Aktteva Biopharma Recent Development
Table 153. Shenyang Antibiotic Manufacturer Company Information
Table 154. Shenyang Antibiotic Manufacturer Introduction and Business Overview
Table 155. Shenyang Antibiotic Manufacturer Rifamycin SV Monosodium Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2024)
Table 156. Shenyang Antibiotic Manufacturer Rifamycin SV Monosodium Product
Table 157. Shenyang Antibiotic Manufacturer Recent Development
Table 158. Zhejiang Hengtengfu Biological Technology Group Company Information
Table 159. Zhejiang Hengtengfu Biological Technology Group Introduction and Business Overview
Table 160. Zhejiang Hengtengfu Biological Technology Group Rifamycin SV Monosodium Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2024)
Table 161. Zhejiang Hengtengfu Biological Technology Group Rifamycin SV Monosodium Product
Table 162. Zhejiang Hengtengfu Biological Technology Group Recent Development
Table 163. Wuhan Fortuna Chemical Company Information
Table 164. Wuhan Fortuna Chemical Introduction and Business Overview
Table 165. Wuhan Fortuna Chemical Rifamycin SV Monosodium Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2024)
Table 166. Wuhan Fortuna Chemical Rifamycin SV Monosodium Product
Table 167. Wuhan Fortuna Chemical Recent Development
Table 168. Hubei Rishengchang New Material Technology Company Information
Table 169. Hubei Rishengchang New Material Technology Introduction and Business Overview
Table 170. Hubei Rishengchang New Material Technology Rifamycin SV Monosodium Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2024)
Table 171. Hubei Rishengchang New Material Technology Rifamycin SV Monosodium Product
Table 172. Hubei Rishengchang New Material Technology Recent Development
Table 173. Jiang Xi Revere Biotechnology Company Information
Table 174. Jiang Xi Revere Biotechnology Introduction and Business Overview
Table 175. Jiang Xi Revere Biotechnology Rifamycin SV Monosodium Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2024)
Table 176. Jiang Xi Revere Biotechnology Rifamycin SV Monosodium Product
Table 177. Jiang Xi Revere Biotechnology Recent Development
Table 178. Shanghai Yuanye Bio-Technology Company Information
Table 179. Shanghai Yuanye Bio-Technology Introduction and Business Overview
Table 180. Shanghai Yuanye Bio-Technology Rifamycin SV Monosodium Sales (Tons), Revenue (Million USD), Price (US$/Ton) and Gross Margin (2018-2024)
Table 181. Shanghai Yuanye Bio-Technology Rifamycin SV Monosodium Product
Table 182. Shanghai Yuanye Bio-Technology Recent Development
Table 183. Key Raw Materials Lists
Table 184. Raw Materials Key Suppliers Lists
Table 185. Rifamycin SV Monosodium Market Trends
Table 186. Rifamycin SV Monosodium Market Drivers
Table 187. Rifamycin SV Monosodium Market Challenges
Table 188. Rifamycin SV Monosodium Market Restraints
Table 189. Rifamycin SV Monosodium Distributors List
Table 190. Rifamycin SV Monosodium Downstream Customers
Table 191. Research Programs/Design for This Report
Table 192. Key Data Information from Secondary Sources
Table 193. Key Data Information from Primary Sources
List of Figures
Figure 1. Rifamycin SV Monosodium Product Picture
Figure 2. Global Rifamycin SV Monosodium Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Rifamycin SV Monosodium Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Rifamycin SV Monosodium Sales Status and Outlook (2018-2029) & (Tons)
Figure 5. Product Picture of Purity Less Than 98%
Figure 6. Global Purity Less Than 98% Sales YoY Growth (2018-2029) & (Tons)
Figure 7. Product Picture of Purity 98%-99%
Figure 8. Global Purity 98%-99% Sales YoY Growth (2018-2029) & (Tons)
Figure 9. Product Picture of Purity Greater Than 99%
Figure 10. Global Purity Greater Than 99% Sales YoY Growth (2018-2029) & (Tons)
Figure 11. Global Rifamycin SV Monosodium Sales by Type (2018-2029) & (US$ Million)
Figure 12. Global Rifamycin SV Monosodium Sales Market Share by Type in 2022 & 2029
Figure 13. North America Rifamycin SV Monosodium Sales Market Share in Volume by Type in 2022
Figure 14. North America Rifamycin SV Monosodium Sales Market Share in Value by Type in 2022
Figure 15. Europe Rifamycin SV Monosodium Sales Market Share in Volume by Type in 2022
Figure 16. Europe Rifamycin SV Monosodium Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Rifamycin SV Monosodium Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Rifamycin SV Monosodium Sales Market Share in Value by Type in 2022
Figure 19. Latin America Rifamycin SV Monosodium Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Rifamycin SV Monosodium Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Rifamycin SV Monosodium Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Rifamycin SV Monosodium Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Rifamycin SV Monosodium Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Rifamycin SV Monosodium Revenue in 2022
Figure 25. Rifamycin SV Monosodium Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Bacterial Infections
Figure 27. Global Bacterial Infections Sales YoY Growth (2018-2029) & (Tons)
Figure 28. Product Picture of Leprosy
Figure 29. Global Leprosy Sales YoY Growth (2018-2029) & (Tons)
Figure 30. Product Picture of Others
Figure 31. Global Others Sales YoY Growth (2018-2029) & (Tons)
Figure 32. Global Rifamycin SV Monosodium Sales by Application (2018-2029) & (US$ Million)
Figure 33. Global Rifamycin SV Monosodium Sales Market Share by Application in 2022 & 2029
Figure 34. North America Rifamycin SV Monosodium Sales Market Share in Volume by Application in 2022
Figure 35. North America Rifamycin SV Monosodium Sales Market Share in Value by Application in 2022
Figure 36. Europe Rifamycin SV Monosodium Sales Market Share in Volume by Application in 2022
Figure 37. Europe Rifamycin SV Monosodium Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Rifamycin SV Monosodium Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Rifamycin SV Monosodium Sales Market Share in Value by Application in 2022
Figure 40. Latin America Rifamycin SV Monosodium Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Rifamycin SV Monosodium Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Rifamycin SV Monosodium Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Rifamycin SV Monosodium Manufacturing Cost Structure
Figure 45. Rifamycin SV Monosodium Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries